6640--Molecular Assay Analyzer(s)

Form / Attachment / Pricing Sheet

This document is the "52.225-2 Buy American Act Certificate (Tailored) Commercially available off-the-shelf (COTS)". It is used by offerors to certify the domestic content of products offered in response to a solicitation.

• Solicitation, Procurement Name, and Location: Fields to identify the specific contract opportunity.
• Completion Instructions: Guidance on how to complete the certificate, including listing foreign end products, indicating if they exceed 55% domestic content, and certifying if all items are domestically produced.
• Foreign End Products Table: Requires Line Item No., Country of Origin, and whether the product exceeds 55% domestic content (Yes/No) for each foreign end product offered. Additional pages can be added as needed.
• Domestic Product Certification: A checkbox to certify that all listed items are domestically produced.
• Signature Block: Fields for Signature, Printed Name, Company, and Title of the person completing the certificate.

Bidders must complete and submit this certificate as part of their proposal to demonstrate compliance with the Buy American Act requirements. Failure to properly complete this form may impact the evaluation of their offer.

Solicitation / RFP / RFQ

This solicitation is for the procurement of a random-access multiplex testing platform, specifically a Molecular Assay Analyzer and an Uninterruptable Power Source, for the Department of Pathology and Laboratory (PLM) at the Iowa City VA Health Care System. The platform must provide quantitative, semi-quantitative, or qualitative determination of various infectious agents.

• Molecular Assay Analyzer: Must be a random-access multiplex testing platform capable of testing for Hepatitis C Virus (HCV), Human Immunodeficiency Virus (HIV-1), Human Papilloma Virus (high-risk), STI Panel (Chlamydia trachomatis, Neisseria gonorrhea, Trichomonas vaginalis, Mycoplasma genitalium), Respiratory Panel (SARS-COV-2, Influenza A, Influenza B, RSV), Herpes Simplex Virus 1 & 2, and Varicella Zoster Virus (VZV).

• Analyzer Performance: Minimum throughput of 300 tests/8-hour shift, compatible with SurePath collection devices, load-on-the-fly capabilities, clinically insignificant carryover, ability to repeat/reflex test, auto-rerun/auto-dilute, minimum 15 reagent slots, error-proof reagent labeling, reagent inventory monitoring, accommodates multiple tube/vial sizes, liquid level sensing, clot/foam/bubble detection. Footprint must not exceed 100" L x 42" W x 76" H. Must be compatible with standard U.S. electrical outlets (120V/240V) and interfaceable with laboratory information systems (Vista and Oracle) or middleware.

• Uninterruptable Power Source (UPS): Required for the analyzer.

• Contract Type: Firm-Fixed-Price.

• Period of Performance: Base contract period begins 07-06-2026 and ends 09-06-2026.

• Estimated Value: Not explicitly stated in the provided sections.

• Submission: Offers must be submitted by the due date of 06-25-2026 at 10:00 CDT.

• Evaluation: Quotes will be evaluated on a best-value tradeoff basis considering Technical, Past Performance, Delivery, Veterans Involvement, and Price. Technical and Delivery are significantly more important than Price.

• Key Deadlines: Offer due date is 06-25-2026.

• Set-Aside: This acquisition is UNRESTRICTED.

• NAICS Code: 334516 (Analytical Laboratory Instrument Manufacturing) with a size standard of 1000 employees.

• Registration: Offerors must be registered and active in the System for Award Management (SAM) at the time of offer.

• Offerors must refer to the "Salient Characteristics" for detailed requirements.

• Failure to return a signed "Buy American Act" waiver may result in a determination of non-responsibility.

• The solicitation includes numerous FAR and VAAR clauses and provisions covering contract terms, representations, certifications, and security requirements.

Solicitation / RFP / RFQ

This is a combined synopsis/solicitation for commercial items, specifically for Molecular Assay Analyzer(s) for the Iowa City VA Health Care System. The solicitation number is 36C26326Q0846 and it is issued as a Request for Quotation (RFQ).

• Procurement of Lab Analyzer(s).

• Additional requirements are detailed within the attached solicitation document.

• Not specified in the provided text.

• This procurement is for Full and Open Competition.

• Technical questions are due via email to steve.ashby@va.gov by 10:00 am CST on 06/22/2026.

• Responses (quotes) are due by 10:00 am CST on 06/25/2026 and must be emailed to steve.ashby@va.gov.

• Offerors are responsible for ensuring their complete quote is received by the Contracting Officer before the closing date and time.

• Prospective offerors must be registered and current in the System for Award Management (SAM) database at the time of offer.

• The Product/Service Code is 6640 and the NAICS Code is 334516.

• The Place of Performance is Iowa City VA Health Care System, Iowa City, IA 52246-2209.

• Referenced attachments include: S03 36C26326Q0846 and P03.1 52.225-2 Buy American Act Certificate.